Loading
PDBj
メニューPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

4ZRO

2.1 A X-Ray Structure of FIPV-3CLpro bound to covalent inhibitor

4ZRO の概要
エントリーDOI10.2210/pdb4zro/pdb
関連するBIRD辞書のPRD_IDPRD_002174
分子名称3C-like proteinase, Bounded inhibitor of N-(tert-butoxycarbonyl)-L-seryl-L-valyl-N-{(2S)-5-ethoxy-5-oxo-1-[(3S)-2-oxopyrrolidin-3-yl]pentan-2-yl}-L-leucinamide, DIMETHYL SULFOXIDE, ... (4 entities in total)
機能のキーワードcoronavirus, main protease, 3clpro, mpro, fipv, fcov, inhibitor complex, feline infectious peritonitis, hydrolase-hydrolase inhibitor complex, hydrolase/hydrolase inhibitor
由来する生物種Feline coronavirus (strain FIPV WSU-79/1146) (FCoV)
詳細
タンパク質・核酸の鎖数8
化学式量合計133587.53
構造登録者
St John, S.E.,Mesecar, A.D. (登録日: 2015-05-12, 公開日: 2015-10-14, 最終更新日: 2025-04-02)
主引用文献St John, S.E.,Therkelsen, M.D.,Nyalapatla, P.R.,Osswald, H.L.,Ghosh, A.K.,Mesecar, A.D.
X-ray structure and inhibition of the feline infectious peritonitis virus 3C-like protease: Structural implications for drug design.
Bioorg.Med.Chem.Lett., 25:5072-5077, 2015
Cited by
PubMed Abstract: Feline infectious peritonitis (FIP) is a deadly disease that effects both domestic and wild cats and is caused by a mutation in feline coronavirus (FCoV) that allows the virus to replicate in macrophages. Currently, there are no treatments or vaccines available for the treatment of FIP even though it kills approximately 5% of cats in multi-cat households per year. In an effort to develop small molecule drugs targeting FIP for the treatment of cats, we screened a small set of designed peptidomimetic inhibitors for inhibition of FIPV-3CL(pro), identifying two compounds with low to sub-micromolar inhibition, compound 6 (IC50=0.59±0.06 μM) and compound 7 (IC50=1.3±0.1 μM). We determined the first X-ray crystal structure of FIPV-3CL(pro) in complex with the best inhibitor identified, compound 6, to a resolution of 2.10 Å to better understand the structural basis for inhibitor specificity. Our study provides important insights into the structural requirements for the inhibition of FIPV-3CL(pro) by peptidomimetic inhibitors and expands the current structural knowledge of coronaviral 3CL(pro) architecture.
PubMed: 26592814
DOI: 10.1016/j.bmcl.2015.10.023
主引用文献が同じPDBエントリー
実験手法
X-RAY DIFFRACTION (2.0566 Å)
構造検証レポート
Validation report summary of 4zro
検証レポート(詳細版)ダウンロードをダウンロード

237992

件を2025-06-25に公開中

PDB statisticsPDBj update infoContact PDBjnumon